Table 3.
Prospective studies conducted in human immunodeficiency virus/hepatitis C virus co-infected patients undergoing liver transplantation
| n | Patient survival | Incidence of ACR | Risk factors for death amongst HIV/HCV recipients1 | |
| Miro et al[65], 2012 | HIV/HCV - 84 | 1, 3, 5 yr: 88%, 62%, 54% | 38% | HCV G1 |
| HCV - 252 | 1, 3, 5 yr: 90%, 76%, 71%1 | 20%1 | Donor risk index | |
| MELD score | ||||
| Center < 1 transplant/yr2 | ||||
| Terrault et al[66], 2012 | HIV/HCV - 89 | 1 and 3 yr: 92% and 79% | 39% | Combined liver-kidney transplant |
| HCV - 235 | 1 and 3 yr: 76% and 60%1 | 24%1 | BMI < 21 | |
| Anti-HCV positive donor | ||||
| Older donor |
1
Statistically significant (P < 0.05);
2
Less than one liver transplant per year in a human immunodeficiency virus (HIV)-infected patient. HCV: Hepatitis C virus; BMI: Body mass index; ACR: Acute cellular rejection.